Maryland Subject | Pharmacy Benefits Managers | House

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
MDHB932PassAltering and establishing requirements and prohibitions related to health insurance utilization review; altering requirements related to internal grievance procedures and adverse decision procedures; altering certain reporting requirements on health ...
[Detail][Text][Discuss]
2024-05-16
Approved by the Governor - Chapter 847
MDHB876Engross

Sine Die
Prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from excluding coverage for certain specialty drugs that are administered or dispensed by a provider that meets certain criteria; and requiring the rei...
[Detail][Text][Discuss]
2024-03-18
To Senate Finance Committee
MDHB1270Intro

Sine Die
Requiring that the calculation of an enrollee's contribution to a cost sharing requirement for a prescription drug be based on the list price of the drug reduced by at least 85% of the total amount of rebates received or expected to be received by th...
[Detail][Text][Discuss]
2024-03-16
Withdrawn by Sponsor
MDHB726Engross

Sine Die
Altering the definition of "purchaser" for the purpose of certain provisions of State insurance law governing pharmacy benefits managers to exclude certain nonprofit health maintenance organizations; and repealing certain provisions that restrict app...
[Detail][Text][Discuss]
2024-03-14
To Senate Finance Committee
MDHB879Engross

Sine Die
Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to include certain discounts, financial assistance payments, product vouchers, and other out-of-pocket expenses made by or on behalf of an insured or enr...
[Detail][Text][Discuss]
2024-03-14
To Senate Finance Committee
MDHB736Intro

Sine Die
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal...
[Detail][Text][Discuss]
2024-02-26
Withdrawn by Sponsor
MDHB880Intro

Sine Die
Altering the reimbursement levels for drug products that the Maryland Medical Assistance Program is required to establish and that pharmacy benefits managers that contract with a pharmacy on behalf of a managed care organization are required to reimb...
[Detail][Text][Discuss]
2024-02-09
To House Health and Government Operations Committee
MDHB1368Intro

Sine Die
Prohibiting certain health insurance entities from taking certain actions with respect to the dispensing of clinician-administered drugs and related services; and authorizing certain health insurance entities to allow the use of a certain pharmacy or...
[Detail][Text][Discuss]
2024-02-09
To House Health and Government Operations Committee
Syndicate content
feedback